The team at John Flynn are always committed to providing a high quality service. Professional guidance is provided on eye-care, glasses and contact lenses. Emphasis is always placed on a personal service, correctly fitted frames and accurately dispensed ophthalmic lenses.

‘We are an independent practice based on Devonshire Avenue in the heart of Beeston, Nottingham. Our focus is always on providing a truly comprehensive and personal eye-care and eye-wear service, that offers patients and clients the reassurance that their eye sight and spectacles are being looked after by qualified Dispensing Opticians, Optometrists (Ophthalmic Opticians) and support staff.’

Breakthrough treatment for DRY AMD eye problems are now available locally. 

Age-related macular degeneration (AMD) is an eye disease that leads to vision loss and can cause blindness. The dry form affects 80% of individuals with AMD.

It tends to progress more slowly than the wet type but leads to a subsequent loss of visual acuity. In dry AMD, drusen can form below the macula over time, causing a progressive loss of central vision.

“I’d had no sight loss as yet with my AMD but I did notice an improvement on my Amsler test – less wavy lines and greyness after treatment. THANKYOU!! Dr Janjua is so thorough and took time to explain my sight and AMD. Wendy and Sonia were so warm and friendly plus professional when giving the treatment.” - Mrs Trueman

As we age, our sight tends to become less clear, and some of us will develop what is known as “Dry Age-related Macular Degeneration”. When this happens, the central area of our vision darkens and becomes blurred, making it difficult to see detail, and preventing activities such as driving, reading, watching TV, using computers, tablets, and so on. Even recognising faces can prove difficult.

Great British Life:

‘Until recently, there were no effective treatments for Dry AMD, the only suggestions being lifestyle changes or dietary supplements. Now, sufferers will be delighted to learn that there is a newly developed treatment available locally. It is a safe, non-invasive, painless therapy which is fully approved under European and UK directives.’

“The treatment was very quick, painless and easy. Improvement of vision it was clearer, new spectacle lenses were needed to allow for improved vision. Very friendly staff and we are very fortunate to have this treatment locally.” - S.Clarke

This breakthrough treatment is known as photobiomodulation (PBT or PBM) and uses a cold laser system to produce low levels of red, yellow and infra-red light to stimulate the centre of vision by energising and providing oxygen for cell repair. Results from extensive monitored trials of the therapy show that for many Dry AMD sufferers, there can be an improvement in sharpness of vision corresponding to some 5 or 8 extra letters on the testing chart.

Several studies have recently shown encouraging results treating eye disease, such as AMD with a technique known as photobiomodulation (PBM).

The process is not a heat therapy but is more akin to photosynthesis in plants or 'Physiotherapy for the eye'.

Light, in the far red and near-infrared spectral range, can stimulate the cells, which lead to a cascade of photochemical reactions. This may facilitate the repair of damaged tissue in the retina and promote function.

The original study (LightSite 1) was undertaken in Canada with patients given 9 treatments over a 3 to 4 week period. The patients were tested before treatment and the 1 month after treatment and the majority had intermediate to advanced AMD.

Results, 50% of PBM treated patients showed an improvement of 5 or more letters, with 92% of patients with no Geographical Atrophy at the start responding. At the same time contrast sensitivity improved and in a group of patients, drusen volumes were seen to fall.

“So pleased there has been an improvement. Sight is invaluable and I hope to preserve what I have. Thank you!!” - Mrs Lewis-Jones

A second study (LightSite 2) was set up in Europe, with the UK, France, Germany, Italy, and Spain taking part using a similar regime of 9 treatments in 3 to 4 weeks. While interrupted by Covid which reduced the recruitment of patients, the interim results have been similarly striking.

Great British Life:

These patients were at an earlier stage in the disease and had better vision to begin with however 35% of PBM treated patients had 5 or more letters of improvement. At the same time the growth rate of Geographical Atrophy was decreased by 44% at 10 months.

Dry AMD gradually impacts your vision through the following:

Loss of vision: As AMD progresses, your central focus may become smudged, distorted or lost. This impacts driving, recognizing faces, reading, watching TV, and other aspects of your life.

Loss of contrast: It becomes more difficult to see textures and contrasts. This can cause difficulty with navigation uneven walkways and stairs leading to an increased risk of falling.

Impaired depth perception: Difficulty with properly judging distances can lead to accidents and falls.

Poor tolerance for changing light levels: Difficulty with adjusting to changing light levels and worsening glare.

Need for brighter light levels: More light may be needed for daily activities such as reading, cooking and other everyday tasks.

“Would recommend Flynn’s wholeheartedly, very professional and knowledgeable and excellent service from all staff.” - Mrs E Hartley

“Excellent, no difficulties and a very easy and comfortable experience splendid staff. Improvement noticed after five sessions, spectacular final result. Dr Janjua and his excellent team are top of the range!” - P. Dawson

Please call 0115 925 5051 or 0115 939 2421 to arrange an appointment.

Open Monday to Friday from 9am to 5:30pm. Saturday 9am-5pm

John Flynn Opticians welcomes the registration of new patients and parking is available in the practice’s own car park.

Telephone 0115 925 5051 / 0115 939 2421 to make an appointment.

Alternatively, you can email or visit their website at:

1a Devonshire Ave, Beeston, Nottingham NG9 1BS

Great British Life: